Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 9
1979 5
1980 7
1981 8
1982 10
1983 9
1984 10
1985 20
1986 15
1987 19
1988 17
1989 13
1990 16
1991 22
1992 29
1993 26
1994 29
1995 34
1996 37
1997 47
1998 49
1999 17
2000 14
2001 10
2002 19
2003 19
2004 14
2005 20
2006 17
2007 21
2008 19
2009 33
2010 39
2011 36
2012 35
2013 51
2014 52
2015 55
2016 42
2017 65
2018 59
2019 67
2020 77
2021 101
2022 67
2023 73
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

1,317 results

Results by year

Filters applied: . Clear all
Page 1
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Querol L, Lleixà C. Querol L, et al. Neurotherapeutics. 2021 Oct;18(4):2222-2235. doi: 10.1007/s13311-021-01117-3. Epub 2021 Sep 21. Neurotherapeutics. 2021. PMID: 34549385 Free PMC article. Review.
Inflammatory neuropathies are a heterogeneous group of rare diseases of the peripheral nervous system that include acute and chronic diseases, such as Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The etiology and patho …
Inflammatory neuropathies are a heterogeneous group of rare diseases of the peripheral nervous system that include acute and chronic disease …
Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F, Lucke IM, Querol LA, Rajabally YA, Verhamme C. Eftimov F, et al. Brain. 2020 Dec 5;143(11):3214-3224. doi: 10.1093/brain/awaa265. Brain. 2020. PMID: 33155018 Free PMC article. Review.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) consists of a spectrum of autoimmune diseases of the peripheral nerves, causing weakness and sensory symptoms. ...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) consists of a spectrum of autoimmune diseases of the peripheral nerv …
Rehabilitation of Guillain-Barré syndrome.
Meythaler JM. Meythaler JM. Arch Phys Med Rehabil. 1997 Aug;78(8):872-9. doi: 10.1016/s0003-9993(97)90203-3. Arch Phys Med Rehabil. 1997. PMID: 9344309 Review.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.
Svačina MKR, Lehmann HC. Svačina MKR, et al. Curr Pharm Des. 2022;28(11):854-862. doi: 10.2174/1381612828666220325102840. Curr Pharm Des. 2022. PMID: 35339172 Review.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated polyradiculoneuropathy leading to disability via inflammatory demyelination of peripheral nerves. ...
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated polyradiculoneuropathy leading to disability …
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database.
Doneddu PE, Cocito D, Manganelli F, Fazio R, Briani C, Filosto M, Benedetti L, Mazzeo A, Marfia GA, Cortese A, Fierro B, Jann S, Beghi E, Clerici AM, Carpo M, Schenone A, Luigetti M, Lauria G, Antonini G, Rosso T, Siciliano G, Cavaletti G, Liberatore G, Santoro L, Peci E, Tronci S, Ruiz M, Cotti Piccinelli S, Toscano A, Mataluni G, Piccolo L, Cosentino G, Sabatelli M, Nobile-Orazio E; Italian CIDP Database study group. Doneddu PE, et al. J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):125-132. doi: 10.1136/jnnp-2018-318714. Epub 2018 Oct 8. J Neurol Neurosurg Psychiatry. 2019. PMID: 30297520 Free article.
OBJECTIVES: A few variants of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have been described, but their frequency and evolution to typical CIDP remain unclear. ...
OBJECTIVES: A few variants of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have been described, but their frequen …
Paraneoplastic neuropathies.
Graus F, Dalmau J. Graus F, et al. Curr Opin Neurol. 2013 Oct;26(5):489-95. doi: 10.1097/WCO.0b013e328364c020. Curr Opin Neurol. 2013. PMID: 23892629 Review.
Update on therapy of chronic immune-mediated neuropathies.
Briani C, Cocito D, Campagnolo M, Doneddu PE, Nobile-Orazio E. Briani C, et al. Neurol Sci. 2022 Dec;43(Suppl 2):605-614. doi: 10.1007/s10072-020-04998-y. Epub 2021 Jan 16. Neurol Sci. 2022. PMID: 33452933 Review.
Chronic immune-mediated neuropathies, including chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), neuropathies associated with monoclonal gammopathy, and multifocal motor neuropathy (MMN), are a group of disorders deemed to be caused by an immune response a …
Chronic immune-mediated neuropathies, including chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), neuropathies associ …
Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study.
Liu B, Hu J, Sun C, Qiao K, Xi J, Zheng Y, Sun J, Luo S, Zhao Y, Lu J, Lin J, Zhao C. Liu B, et al. J Neurol. 2023 Sep;270(9):4288-4295. doi: 10.1007/s00415-023-11759-2. Epub 2023 May 17. J Neurol. 2023. PMID: 37195346
The clinical and pathological characteristics of the disease are distinct from that of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and the standard treatment for CIDP is partially effective. ...
The clinical and pathological characteristics of the disease are distinct from that of chronic inflammatory demyelinating polyradiculoneu …
Immune-mediated diseases involving central and peripheral nervous systems.
Leboyan A, Esselin F, Bascou AL, Duflos C, Ion I, Charif M, Castelnovo G, Carra-Dalliere C, Ayrignac X, Kerschen P, Chbicheb M, Nguyen L, Maria ATJ, Guilpain P, Carriere M, de Champfleur NM, Vincent T, Jentzer A, Labauge P, Devaux JJ, Taieb G. Leboyan A, et al. Eur J Neurol. 2023 Feb;30(2):490-500. doi: 10.1111/ene.15628. Epub 2022 Nov 27. Eur J Neurol. 2023. PMID: 36366904
Patients were assigned to one of four groups: (i) monophasic disease with concomitant CNS/PNS involvement including anti-GQ1b syndrome (acute polyradiculoneuropathy + rhombencephalitis, n = 2), checkpoint inhibitor-related toxicities (acute polyradiculoneuropathy + …
Patients were assigned to one of four groups: (i) monophasic disease with concomitant CNS/PNS involvement including anti-GQ1b syndrome (acut …
1,317 results